ZION
67
-4
COP
59
2
AIG
44
-3
OI
46
3
NOC
34
-6
UPS
48
-2
ILMN
42
-3
EXC
53
12
PSA
55
-3
KSS
46
4
ETR
65
-3
LMT
34
-5
TAP
60
-4
HPE
48
-22
LNC
43
-2
URBN
55
-11
TSCO
49
-2
CINF
50
-3
PLD
51
-5
CHRW
65
-2
ZION
67
-4
COP
59
2
AIG
44
-3
OI
46
3
NOC
34
-6
UPS
48
-2
ILMN
42
-3
EXC
53
12
PSA
55
-3
KSS
46
4
ETR
65
-3
LMT
34
-5
TAP
60
-4
HPE
48
-22
LNC
43
-2
URBN
55
-11
TSCO
49
-2
CINF
50
-3
PLD
51
-5
CHRW
65
-2
Financhill
Back

Agios Pharmaceuticals Quote, Financials, Valuation and Earnings

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here
Sell
42

AGIO
Agios Pharmaceuticals

Last Price:
53.05
Seasonality Move:
3.07%

7 Day Trial

ALL ACCESS PASS

$ 7

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.

Agios Pharmaceuticals Price Quote

$53.05
-2.35 (-4.24%)
(Updated: November 15, 2024 at 9:50 AM ET)

Agios Pharmaceuticals Key Stats

Sell
42
Agios Pharmaceuticals (AGIO) is a Sell
Day range:
$55.29 - $58.91
52-week range:
$20.96 - $62.58
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
95.87
P/B ratio:
1.94%
Volume:
868.5K
Avg. volume:
610.7K
1-year change:
148.43%
Market cap:
$3.2B
Revenue:
$26.8M
EPS:
$11.36

How Much Does Agios Pharmaceuticals Make?

Is Agios Pharmaceuticals Growing As A Company?

  • What Is Agios Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.21%
  • What Is Agios Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Agios Pharmaceuticals Stock Price Performance

What Is Agios Pharmaceuticals 52-Week High & Low?

Agios Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Agios Pharmaceuticals?

Is Agios Pharmaceuticals Cash Flow Positive?

  • What Is AGIO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$329.2M
  • What Is Agios Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $10.4M
  • What Is Agios Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $508.1M

Agios Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    AGIO return on invested capital is 71.3%
  • What Is Agios Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 62.91%
  • What Is AGIO Return On Equity?
    ROE is a measure of profitability and is 71.3%

Agios Pharmaceuticals Earnings Date & Stock Price

Agios Pharmaceuticals Competitors

Agios Pharmaceuticals Dividend Yield

Agios Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -118.52%
Revenue: 21.15% -5.66%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 53.88
Downside from Last Price: -2.75%

Major Shareholders

  • How many AGIO shares are owned by institutional investors?
    92.2M AGIO shares are owned by institutional investors
  • How many AGIO shares are owned by insiders?
    1.3M AGIO shares are owned by insiders